Hello, everyone. Nice to see you again. A busy day is under way here at the Pharmalot corporate campus where we are chasing various short people off to the schoolhouse. And then there are those meetings and deadlines. No doubt, you can relate. So time to reach for the mandatory cup of stimulation and scan the news of the world. Have a good one...
Elan CEO To Quit In 2012 (Reuters)
USP Forges Stronger Ties To Russia And Ukraine (InPharmaTechnologist)
Avandia Helps Prevent Diabetes In Low-Dose Combo (Bloomberg News)
Orexo And J&J Sign Respiratory Disease Deal (PharmaTimes)
FDA Panel Rejects AstraZeneca Infant Lung Drug (Bloomberg News)
FDA Panel To Review Arena Diet Pill (Reuters)
New Zealand To Review Recalls (Stuff)